Edward Kim

Academic / Other · 3 registered clinical trials.

Status	Trial	Phase	Started
Terminated	BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8	Phase 1 / Phase 2	2018-10-16
Completed	Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy Colon Adenocarcinoma	N/A	2015-10-16
Completed	Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer	Phase 1	2013-08-09